<DOC>
	<DOCNO>NCT00814567</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-ray kill tumor cell . Giving radiation therapy surgery may kill tumor cell remain surgery . It yet know whether intensity-modulated radiation therapy effective standard radiation therapy treat patient early-stage breast cancer . PURPOSE : This randomized phase III trial compare radiation therapy regimens treat woman early-stage breast cancer undergone breast-conservation surgery .</brief_summary>
	<brief_title>Radiation Therapy Treating Women With Early-Stage Breast Cancer Who Have Undergone Breast Conservation Surgery</brief_title>
	<detailed_description>OBJECTIVES : - To test partial breast radiotherapy use intensity-modulated technique follow complete local tumor excision woman low-risk , early stage breast cancer . OUTLINE : This multicenter study . Patients stratify accord center ( participate sub-studies vs participate sub-studies ) . Patients randomize 1 3 treatment arm . - Arm I ( control ) : Patients undergo standard whole breast radiotherapy daily day 1-5 ( 15 fraction ) 3 week . - Arm II : Patients undergo reduce whole breast radiotherapy ( 15 fraction ) standard partial breast radiotherapy ( 15 fraction ) daily day 1-5 3 week . - Arm III : Patients undergo standard partial breast radiotherapy daily day 1-5 ( 15 fraction ) 3 week . All patient complete family history questionnaire baseline . Patients also undergo blood sample collection baseline paraffin-embedded tissue collection follow-up molecular study analyze inter-patient variation microarrays . Patients center participate sub-studies undergo quality life health economic assessment baseline , 6 month , 1 , 2 , 5 year . These patient also undergo photographic assessment baseline , 2 year , 5 year . After completion study treatment , patient follow 10 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis lowrisk early stage breast cancer , meet follow criterion : Invasive adenocarcinoma No invasive carcinoma classical lobular type No lymphovascular invasion Tumor size pathologically determine ≤ 3.0 cm diameter ( pT12 ) ( &lt; 3.1 cm maximum microscopic diameter invasive component ) Unifocal disease Grade I , II , III disease Axillary lymph node negative ( pN0 ) Sentinel lymph node biopsy isolate tumor cell &lt; 0.2 mm allow Must undergone breast conservation surgery without adjuvant systemic therapy Minimum microscopic margin noncancerous tissue ≥ 2 mm ( exclude deep margin deep fascia ) At low risk local recurrence radiotherapy ( &lt; 1 % annual risk local recurrence ) No prior mastectomy No bloodborne metastases PATIENT CHARACTERISTICS : No prior malignancy except nonmelanoma skin cancer PRIOR CONCURRENT THERAPY : See Disease Characteristics No prior endocrine therapy chemotherapy Neoadjuvant endocrine therapy allow provide tumour &lt; 3.0 cm inclusion criterion meet No primary endocrine therapy replacement surgery No concurrent chemoradiotherapy</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>recurrent breast cancer</keyword>
	<keyword>stage IA breast cancer</keyword>
	<keyword>stage II breast cancer</keyword>
	<keyword>invasive ductal breast carcinoma</keyword>
	<keyword>invasive ductal breast carcinoma predominant intraductal component</keyword>
</DOC>